Cancer Epidemiology, Biomarkers & Prevention

Cancer Epidemiology, Biomarkers & Prevention (CEBP) is a peer-reviewed medical journal that focuses on research in the field of cancer epidemiology, biomarkers in cancer research, and cancer prevention. The journal serves as a comprehensive resource for scientists, clinicians, and public health professionals by publishing original research articles, reviews, and commentaries that provide significant insights into the mechanisms of cancer, potential therapeutic targets, and strategies for cancer prevention.

Scope and Focus

The primary aim of Cancer Epidemiology, Biomarkers & Prevention is to enhance our understanding of the etiology and prevention of cancer. The journal emphasizes studies that contribute to the identification of new biomarkers for cancer detection, diagnosis, and treatment. It also covers research on genetic, environmental, and lifestyle factors that can influence cancer risk, as well as investigations into the implementation of preventive strategies and public health policies.

Research Areas

• Cancer Epidemiology: The journal publishes epidemiological studies that explore the distribution, determinants, and frequency of cancer. This includes research on cancer risk factors, cancer incidence, and cancer mortality across different populations.
• Biomarkers in Cancer: A significant portion of the journal is dedicated to studies on biomarkers that can be used for cancer screening, diagnosis, prognosis, and monitoring response to treatment. This encompasses genetic, proteomic, and metabolic markers.
• Cancer Prevention: CEBP is interested in research that investigates preventive measures, including vaccination, dietary interventions, lifestyle changes, and chemoprevention. Studies on the effectiveness of public health campaigns and policies in reducing cancer risk are also welcomed.

Submission and Review Process

The journal employs a rigorous peer-review process to ensure the quality and relevance of submitted manuscripts. Authors are encouraged to submit original research, review articles, and brief reports that adhere to the journal's scope. The review process is designed to be fair, unbiased, and timely, providing constructive feedback to authors.

Impact

Cancer Epidemiology, Biomarkers & Prevention has established itself as a leading journal in its field, recognized for its contribution to advancing knowledge on cancer prevention and early detection. The journal's impact factor, a measure of the frequency with which its articles are cited, reflects its influence and relevance in the field of oncology and public health.

Editorial Board

The journal is supported by an international editorial board comprising experts in cancer research, epidemiology, and public health. The board is responsible for guiding the journal's direction, ensuring the quality of published content, and fostering advancements in the field.

Access and Distribution

CEBP is available in both print and online formats, providing accessible content to researchers, clinicians, and the public. The journal encourages the dissemination of its findings to a broad audience to promote the application of research in clinical practice and public health initiatives.